The majority of these cases encompassed pathogenic RYR1 variants in core myopathy, NEB and ACTA1 in nemaline myopathy, and pathogenic MTM1 variants in CNM (Fig. 3). This evidence concerns the gene RYR1 and nemaline myopathy.